Sign In
Buy CGNT
Cognyte Software Earnings Calls
| Release date | Jun 03, 2026 |
| EPS estimate | $0.100 |
| EPS actual | $0.0300 |
| EPS Surprise | -70.00% |
| Revenue estimate | 105.041M |
| Revenue actual | 105.494M |
| Revenue Surprise | 0.431% |
| Release date | Mar 25, 2026 |
| EPS estimate | $0.0100 |
| EPS actual | $0.100 |
| EPS Surprise | 900.00% |
| Revenue estimate | 106.282M |
| Revenue actual | 106.242M |
| Revenue Surprise | -0.0372% |
| Release date | Dec 09, 2025 |
| EPS estimate | -$0.0200 |
| EPS actual | $0.0300 |
| EPS Surprise | 250.00% |
| Revenue estimate | 106.214M |
| Revenue actual | 100.738M |
| Revenue Surprise | -5.16% |
| Release date | Sep 09, 2025 |
| EPS estimate | $0.0250 |
| EPS actual | $0.0800 |
| EPS Surprise | 220.00% |
| Revenue estimate | 99.557M |
| Revenue actual | 97.513M |
| Revenue Surprise | -2.05% |
Last 4 Quarters for Cognyte Software
Below you can see how CGNT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 09, 2025 |
| Price on release | $8.45 |
| EPS estimate | $0.0250 |
| EPS actual | $0.0800 |
| EPS surprise | 220.00% |
| Date | Price |
|---|---|
| Sep 03, 2025 | $8.65 |
| Sep 04, 2025 | $8.69 |
| Sep 05, 2025 | $9.01 |
| Sep 08, 2025 | $9.53 |
| Sep 09, 2025 | $8.45 |
| Sep 10, 2025 | $8.26 |
| Sep 11, 2025 | $8.72 |
| Sep 12, 2025 | $8.52 |
| Sep 15, 2025 | $8.46 |
| 4 days before | -2.31% |
| 4 days after | 0.118% |
| On release day | -2.25% |
| Change in period | -2.20% |
| Release date | Dec 09, 2025 |
| Price on release | $9.72 |
| EPS estimate | -$0.0200 |
| EPS actual | $0.0300 |
| EPS surprise | 250.00% |
| Date | Price |
|---|---|
| Dec 03, 2025 | $8.53 |
| Dec 04, 2025 | $8.57 |
| Dec 05, 2025 | $8.65 |
| Dec 08, 2025 | $8.97 |
| Dec 09, 2025 | $9.72 |
| Dec 10, 2025 | $9.71 |
| Dec 11, 2025 | $9.88 |
| Dec 12, 2025 | $9.87 |
| Dec 15, 2025 | $9.52 |
| 4 days before | 13.89% |
| 4 days after | -2.06% |
| On release day | -0.0515% |
| Change in period | 11.55% |
| Release date | Mar 25, 2026 |
| Price on release | $8.45 |
| EPS estimate | $0.0100 |
| EPS actual | $0.100 |
| EPS surprise | 900.00% |
| Date | Price |
|---|---|
| Mar 19, 2026 | $8.36 |
| Mar 20, 2026 | $7.95 |
| Mar 23, 2026 | $8.15 |
| Mar 24, 2026 | $7.88 |
| Mar 25, 2026 | $8.45 |
| Mar 26, 2026 | $8.07 |
| Mar 27, 2026 | $7.75 |
| Mar 30, 2026 | $7.93 |
| Mar 31, 2026 | $8.10 |
| 4 days before | 1.08% |
| 4 days after | -4.14% |
| On release day | -4.50% |
| Change in period | -3.11% |
| Release date | Jun 03, 2026 |
| Price on release | $9.23 |
| EPS estimate | $0.100 |
| EPS actual | $0.0300 |
| EPS surprise | -70.00% |
| Date | Price |
|---|---|
| May 28, 2026 | $10.53 |
| May 29, 2026 | $11.57 |
| Jun 01, 2026 | $12.24 |
| Jun 02, 2026 | $11.62 |
| Jun 03, 2026 | $9.23 |
| Jun 04, 2026 | $9.25 |
| Jun 05, 2026 | $8.99 |
| Jun 08, 2026 | $9.06 |
| Jun 09, 2026 | $8.91 |
| 4 days before | -12.35% |
| 4 days after | -3.47% |
| On release day | 0.217% |
| Change in period | -15.38% |
Cognyte Software Earnings Call Transcript Summary of Q2 2026
Cognyte reported solid Q2 FY2026 results driven by continued demand for its intelligence and tactical solutions. Revenue grew ~16% YoY to $97.5M, non-GAAP gross profit rose ~17%, and adjusted EBITDA was $11M (up ~33% YoY). Software remains the core of the business (about 85% of revenue this quarter) with recurring revenue at ~49%. Key commercial highlights included two ~ $10M military intelligence wins (one follow-on with an existing Asia‑Pacific customer and one competitive win in EMEA) and progress in U.S. market expansion, including a strategic alliance with LexisNexis Risk Solutions and integration of the GroupSense acquisition. Gross margin expanded to 72.1% in the quarter and management raised FY2026 guidance to revenue of ~$397M (±2%) and adjusted EBITDA of ~$45M. Balance sheet: $84.7M cash, no debt, completed a $20M buyback and announced a new $20M repurchase program; Q2 operating cash flow was negative ~$6M (seasonal), with full‑year operating cash flow expected to be ~$45M. Management reiterated a long‑term target (FY2028) of $500M revenue, ~73% gross margin and >20% adjusted EBITDA margin. Risks noted include U.S. federal procurement timing and sector budget headwinds, which management views as temporary.
